Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer

Summary

The purpose of this study is to treat advanced or recurrent endometrial cancer, paclitaxel-containing regimen is the preferred chemotherapeutic regimen which is selected by most physicians. Docetaxel may have similar efficacy and more favorable treatment related toxicity profile as tested in epithelial ovarian cancer trials. Therefore, the investigators aimed to evaluate the efficacy and safety of docetaxel plus cisplatin in patients with advanced or recurrent endometrial cancer.

Timeline

Start

2011-10

Primary completion

2017-12

Completion

2017-12

Drugs

Indications